Safety study of GlaxoSmithKline (GSK) Biologicals' human papillomavirus (HPV) vaccine in healthy Vietnamese women according to a 0, 1, 6 month schedule
Phase of Trial: Phase III
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary)
- Indications Human papillomavirus infections
- Focus Adverse reactions
- 04 Jan 2008 New trial record.